# Empire State Realty Trust, Inc.: financial statements, quarterly ESRT · NYSE · CIK 1541401 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/esrt.md) · [Financials](/companies/esrt/financials.md) · [Filings](/companies/esrt/filings.md) · [Insiders](/companies/esrt/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/esrt/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [192](/filings/0001541401-24-000038.md) | [192 d](/filings/0001541401-26-000008.md) | [181](/filings/0001541401-25-000014.md) | [189](/filings/0001541401-25-000028.md) | [199](/filings/0001541401-25-000037.md) | [197 d](/filings/0001541401-26-000008.md) | [180](/filings/0001541401-26-000020.md) | [191](/filings/0001541401-26-000033.md) | [197](/filings/0001541401-25-000037.md) | [199 d](/filings/0001541401-26-000008.md) | [190](/filings/0001541401-26-000020.md) | [197](/filings/0001541401-26-000033.md) | | Selling, general and administrative | $m | [16.0](/filings/0001628280-23-037872.md) | [16.1 d](/filings/0001541401-24-000033.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating income | $m | [42.3](/filings/0001541401-24-000038.md) | [40.8 d](/filings/0001541401-26-000008.md) | [31.1](/filings/0001541401-25-000014.md) | [39.4](/filings/0001541401-25-000028.md) | [45.3](/filings/0001541401-25-000037.md) | [42.9 d](/filings/0001541401-26-000008.md) | [25.8](/filings/0001541401-26-000020.md) | [35.1](/filings/0001541401-26-000033.md) | [39.3](/filings/0001541401-25-000037.md) | [35.4 d](/filings/0001541401-26-000008.md) | [29.5](/filings/0001541401-26-000020.md) | [(139)](/filings/0001541401-26-000033.md) | | Interest expense | $m | [25.4](/filings/0001628280-23-037872.md) | [25.4 d](/filings/0001541401-24-000033.md) | [25.1](/filings/0001628280-24-021106.md) | [25.3](/filings/0001541401-25-000028.md) | [27.4](/filings/0001541401-25-000037.md) | [27.4 d](/filings/0001541401-26-000008.md) | [26.9](/filings/0001541401-26-000020.md) | [25.1](/filings/0001541401-26-000033.md) | [25.2](/filings/0001541401-25-000037.md) | [25.9 d](/filings/0001541401-26-000008.md) | [28.1](/filings/0001541401-26-000020.md) | [27.8](/filings/0001541401-26-000033.md) | | Income tax | $m | [1.4](/filings/0001541401-24-000038.md) | [1.8 d](/filings/0001541401-26-000008.md) | [(0.7)](/filings/0001541401-25-000014.md) | [0.8](/filings/0001541401-25-000028.md) | [1.4](/filings/0001541401-25-000037.md) | [1.2 d](/filings/0001541401-26-000008.md) | [(0.6)](/filings/0001541401-26-000020.md) | [0.5](/filings/0001541401-26-000033.md) | [1.6](/filings/0001541401-25-000037.md) | [1.1 d](/filings/0001541401-26-000008.md) | [(1.1)](/filings/0001541401-26-000020.md) | [(0.8)](/filings/0001541401-26-000033.md) | | Net income | $m | [19.9](/filings/0001541401-24-000038.md) | [15.8 d](/filings/0001541401-26-000008.md) | [10.2](/filings/0001541401-25-000014.md) | [28.6](/filings/0001541401-25-000028.md) | [22.8](/filings/0001541401-25-000037.md) | [18.8 d](/filings/0001541401-26-000008.md) | [15.8](/filings/0001541401-26-000020.md) | [11.4](/filings/0001541401-26-000033.md) | [13.6](/filings/0001541401-25-000037.md) | [32.2 d](/filings/0001541401-26-000008.md) | [3.0](/filings/0001541401-26-000020.md) | [(39.6)](/filings/0001541401-26-000033.md) | | Diluted EPS | $ per share | [0.07](/filings/0001541401-24-000038.md) | not reported | [0.03](/filings/0001541401-25-000014.md) | [0.10](/filings/0001541401-25-000028.md) | [0.08](/filings/0001541401-25-000037.md) | not reported | [0.05](/filings/0001541401-26-000020.md) | [0.04](/filings/0001541401-26-000033.md) | [0.05](/filings/0001541401-25-000037.md) | not reported | [0.01](/filings/0001541401-26-000020.md) | [(0.15)](/filings/0001541401-26-000033.md) | | Basic EPS | $ per share | [0.07](/filings/0001541401-24-000038.md) | not reported | [0.03](/filings/0001541401-25-000014.md) | [0.10](/filings/0001541401-25-000028.md) | [0.08](/filings/0001541401-25-000037.md) | not reported | [0.06](/filings/0001541401-26-000020.md) | [0.04](/filings/0001541401-26-000033.md) | [0.05](/filings/0001541401-25-000037.md) | not reported | [0.01](/filings/0001541401-26-000020.md) | [(0.15)](/filings/0001541401-26-000033.md) | - Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:ProfitLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [354](/filings/0001541401-24-000038.md) | [347](/filings/0001541401-26-000008.md) | [334](/filings/0001541401-25-000014.md) | [536](/filings/0001541401-25-000028.md) | [422](/filings/0001541401-25-000037.md) | [385](/filings/0001541401-26-000033.md) | [188](/filings/0001541401-26-000020.md) | [94.6](/filings/0001541401-26-000033.md) | [154](/filings/0001541401-25-000037.md) | [133](/filings/0001541401-26-000033.md) | [68.8](/filings/0001541401-26-000020.md) | [85.6](/filings/0001541401-26-000033.md) | | Total assets | $m | [4,217](/filings/0001541401-24-000038.md) | [4,219](/filings/0001541401-26-000008.md) | [4,191](/filings/0001541401-25-000014.md) | [4,433](/filings/0001541401-25-000028.md) | [4,437](/filings/0001541401-25-000037.md) | [4,510](/filings/0001541401-26-000008.md) | [4,114](/filings/0001541401-26-000020.md) | [4,079](/filings/0001541401-26-000033.md) | [4,106](/filings/0001541401-25-000037.md) | [4,469](/filings/0001541401-26-000033.md) | [4,406](/filings/0001541401-26-000020.md) | [4,273](/filings/0001541401-26-000033.md) | | Total liabilities | $m | [2,483](/filings/0001628280-23-037872.md) | [2,488](/filings/0001541401-25-000003.md) | [2,466](/filings/0001628280-24-021106.md) | [2,682](/filings/0001541401-24-000035.md) | [2,680](/filings/0001541401-24-000038.md) | [2,728](/filings/0001541401-26-000008.md) | [2,329](/filings/0001541401-25-000014.md) | [2,290](/filings/0001541401-25-000028.md) | [2,308](/filings/0001541401-25-000037.md) | [2,647](/filings/0001541401-26-000033.md) | [2,582](/filings/0001541401-26-000020.md) | [2,483](/filings/0001541401-26-000033.md) | | Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [987](/filings/0001628280-23-037872.md) | [986](/filings/0001541401-25-000003.md) | [996](/filings/0001628280-24-021106.md) | [1,011](/filings/0001541401-24-000035.md) | [1,015](/filings/0001541401-24-000038.md) | [1,031](/filings/0001541401-26-000008.md) | [1,032](/filings/0001541401-25-000014.md) | [1,038](/filings/0001541401-25-000028.md) | [1,044](/filings/0001541401-25-000037.md) | [1,060](/filings/0001541401-26-000033.md) | [1,064](/filings/0001541401-26-000020.md) | [1,039](/filings/0001541401-26-000033.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Total assets: us-gaap:Assets - Total liabilities: us-gaap:Liabilities - Long-term debt: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [90.1 d](/filings/0001541401-24-000038.md) | [36.4 d](/filings/0001541401-26-000008.md) | [70.9](/filings/0001541401-25-000014.md) | [37.1 d](/filings/0001541401-25-000028.md) | [103 d](/filings/0001541401-25-000037.md) | [50.0 d](/filings/0001541401-26-000008.md) | [83.1](/filings/0001541401-26-000020.md) | [26.7 d](/filings/0001541401-26-000033.md) | [105 d](/filings/0001541401-25-000037.md) | [33.9 d](/filings/0001541401-26-000008.md) | [68.9](/filings/0001541401-26-000020.md) | [19.5 d](/filings/0001541401-26-000033.md) | | Capital expenditure | $m | [56.2](/filings/0001541401-24-000038.md) | [45.4 d](/filings/0001541401-24-000033.md) | [47.7](/filings/0001628280-24-021106.md) | [17.6](/filings/0001541401-24-000035.md) | [168](/filings/0001541401-24-000038.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Dividends paid | $m | [5.7](/filings/0001541401-24-000038.md) | [5.7 d](/filings/0001541401-26-000008.md) | [5.8](/filings/0001541401-25-000014.md) | [5.8](/filings/0001541401-25-000028.md) | [5.8](/filings/0001541401-25-000037.md) | [5.8 d](/filings/0001541401-26-000008.md) | [5.9](/filings/0001541401-26-000020.md) | [5.9](/filings/0001541401-26-000033.md) | [5.9](/filings/0001541401-25-000037.md) | [6.0 d](/filings/0001541401-26-000008.md) | [6.0](/filings/0001541401-26-000020.md) | [6.0](/filings/0001541401-26-000033.md) | | Share repurchases | $m | [0.0 d](/filings/0001541401-24-000038.md) | [0.0 d](/filings/0001541401-26-000008.md) | [0.0](/filings/0001628280-24-021106.md) | [0.0 d](/filings/0001541401-25-000028.md) | [0.0 d](/filings/0001541401-25-000037.md) | [0.0 d](/filings/0001541401-26-000008.md) | not reported | not reported | [0.0 d](/filings/0001541401-25-000037.md) | [6.0 d](/filings/0001541401-26-000008.md) | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets - Dividends paid: us-gaap:PaymentsOfDividendsCommonStock - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [267](/filings/0001628280-23-037872.md) | [265](/filings/0001628280-24-021106.md) | [264](/filings/0001541401-24-000035.md) | [266](/filings/0001541401-24-000038.md) | [267](/filings/0001541401-25-000014.md) | [269](/filings/0001541401-25-000028.md) | [270](/filings/0001541401-25-000037.md) | [270](/filings/0001541401-26-000020.md) | [270](/filings/0001541401-26-000033.md) | [270](/filings/0001541401-25-000037.md) | [269](/filings/0001541401-26-000020.md) | [269](/filings/0001541401-26-000033.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.